When HRT Is Not Enough

Educational only. Not medical advice. Persistent symptoms on HRT warrant clinical evaluation - do not simply increase your dose without clinician guidance.

You started HRT. The hot flashes improved. The sleep got better. But something is still not right. Maybe the hot flashes reduced but did not disappear. Maybe your mood is better but not back to baseline. Maybe your energy returned but your brain fog persists. Maybe vaginal symptoms improved but sex is still uncomfortable.

This is common. HRT is the most effective treatment for menopausal symptoms, but “most effective” does not mean “fixes everything for everyone.” Some symptoms require dose or route adjustment. Some require add-on therapy. Some have causes beyond hormonal deficiency that HRT cannot address. Knowing which category you are in prevents the frustrating cycle of dose increases that do not help.

• If vasomotor symptoms persist after 8 to 12 weeks on adequate HRT, the first step is dose or route adjustment - not giving up
• Some symptoms have non-hormonal components that HRT alone will not address (sleep apnea, primary depression, thyroid disease, relationship issues)
• Vaginal symptoms may need local treatment (vaginal estrogen) in addition to systemic HRT
• Adding testosterone is appropriate for HSDD after other causes have been addressed - it is not appropriate as a general “booster” for fatigue or energy
• The goal of HRT optimization is symptom control at the lowest effective dose, not chasing a lab number

Step 1: verify adequacy. Are you absorbing the medication? For topical/transdermal routes, serum estradiol levels confirm absorption. A level below 30 to 40 pg/mL on systemic HRT may indicate underdosing or poor absorption. Are you taking it correctly? Patches applied properly, gels given time to absorb, oral taken consistently.

Step 2: dose adjustment. If levels are subtherapeutic, increase the dose. Typical escalation: oral estradiol from 0.5 mg to 1 mg, or from 1 mg to 1.5-2 mg. Patch from 0.025 mg/day to 0.05 mg/day, or from 0.05 to 0.075-0.1. Give 4 to 6 weeks at each dose before reassessing.

Step 3: route change. Some women absorb oral estrogen well but do not get adequate vasomotor control. Switching to transdermal (which provides more consistent levels without daily peaks and troughs) can help. The reverse is also true.

Step 4: add-on therapy. If vasomotor symptoms persist despite optimized HRT, adding a non-hormonal agent (gabapentin at bedtime, low-dose SSRI/SNRI, or fezolinetant) to HRT can provide additional relief. This combination approach is underutilized.

Step 5: investigate further. Persistent flushing and sweating despite adequate estrogen levels may have non-menopausal causes. Thyroid dysfunction, carcinoid (rare), medications, food triggers, and anxiety can all produce vasomotor-like symptoms.

HRT stabilizes the hormonal environment, which often improves mood. But not all mood symptoms during menopause are purely hormonal. If depression persists on adequate HRT, add an SSRI/SNRI or therapy (CBT, interpersonal therapy). If anxiety persists, evaluate for generalized anxiety disorder, consider therapy and/or anxiolytic medication. If irritability persists, evaluate sleep quality (sleep deprivation alone causes irritability) and relationship stressors.

The test: if mood improved initially on HRT and then plateaued at “better but not right,” the remaining component may need its own treatment. If mood never improved on HRT, the primary driver may not be hormonal.

HRT resolves night sweats for most women within 2-4 weeks. If sleep remains disrupted after night sweats are controlled, the sleep problem has a non-sweats component. Evaluate for sleep apnea (risk increases post-menopause). Consider CBT for insomnia (CBT-I). Review sleep hygiene and medication list. If using progesterone, ensure it is taken at bedtime to leverage sedative effect.

Systemic HRT improves vaginal health but may not fully restore tissue, particularly in women with advanced atrophy. Adding vaginal estrogen alongside systemic HRT provides targeted local treatment that systemic therapy alone may not deliver. Some women need both.

If desire does not improve with adequate systemic HRT and resolved sleep/mood, evaluate for HSDD. Testosterone is the evidence-based option for this specific indication.

If pain persists despite adequate vaginal estrogen, pelvic floor physical therapy can address muscle tension and pain sensitization that estrogen alone does not resolve.

Do not keep increasing estrogen beyond physiologic doses hoping more will fix everything. Supraphysiologic levels increase risk without proportional benefit. Do not add testosterone for general fatigue or “optimization” without a specific HSDD diagnosis. Do not add compounded DHEA, pregnenolone, or adrenal support without evidence-based indications. Do not accept “this is the best we can do” without working through the adjustment steps systematically.

The Systematic Approach: A Checklist

Before concluding that HRT is “not working,” work through this systematically.

Step 1 - Verify absorption. Is your estradiol level in therapeutic range (40 to 100 pg/mL on systemic HRT)? If you are on patches, gels, or cream, absorption varies. A subtherapeutic level is a dosing problem, not a treatment failure.

Step 2 - Verify dose adequacy. Have you reached the optimal dose, or are you still on the starting dose? Many women are undertreated because the initial dose was never increased when symptoms persisted. Your clinician should titrate up before concluding the approach failed.

Step 3 - Verify progestogen tolerance. Could your progestogen be causing symptoms that counteract estrogen’s benefits? Mood changes, bloating, and breast tenderness from progestogen can make women feel worse despite improved vasomotor control. Consider switching progestogen type or route.

Step 4 - Rule out concurrent conditions. Thyroid? Sleep apnea? Depression? Anemia? Vitamin D deficiency? These all produce symptoms that overlap with menopause and will not respond to HRT.

Step 5 - Evaluate lifestyle factors. Alcohol, caffeine, sleep hygiene, exercise, stress. These modulate HRT response. A woman on adequate HRT who drinks three glasses of wine nightly and sleeps 5 hours will still feel terrible.

Step 6 - Consider add-on therapy. SSRI/SNRI for persistent mood symptoms. Gabapentin for residual nocturnal hot flashes. Vaginal estrogen added to systemic for persistent GSM. Each addition addresses a specific remaining symptom.

Step 7 - Specialist referral. If steps 1-6 have been worked through systematically and symptoms persist, referral to a menopause specialist, endocrinologist, or relevant subspecialist is the next step.

The women who “fail” HRT are often women whose HRT was never optimized. The checklist takes time to work through, but it prevents premature abandonment of a treatment that may simply need adjustment.